Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-04 Sale |
2025-04-08 5:32 pm |
OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO |
874 | $2.94 | $2,570 | 3,682 (Direct) |
View |
| 2025-04-04 Sale |
2025-04-08 5:30 pm |
OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer |
3,122 | $2.9398 | $9,178 | 13,209 (Direct) |
View |
| 2024-09-24 Purchase |
2024-09-26 09:33 am |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
98,346 | $1.4717 | $144,738 | 4,478,164 (Indirect Direct) |
View |
| 2024-09-17 Purchase |
2024-09-19 11:02 am |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
56,106 | $1.3588 | $76,237 | 4,379,818 (Indirect Direct) |
View |
| 2024-09-12 Purchase |
2024-09-16 4:15 pm |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
358,923 | $1.3494 | $484,344 | 4,323,712 (Indirect Direct) |
View |
| 2024-08-13 Purchase |
2024-08-14 8:48 pm |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
271,826 | $1.4002 | $380,598 | 3,964,789 (Indirect Direct) |
View |
| 2024-05-14 Purchase |
2024-05-16 08:58 am |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
414,281 | $1.5438 | $639,578 | 3,692,963 (Indirect Direct) |
View |
| 2023-08-28 Sale |
2023-08-29 5:04 pm |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
15,625 | $6.2757 | $98,058 | 148,975 (Direct) |
View |
| 2023-06-23 Sale |
2023-06-23 7:15 pm |
Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner |
100,000 | $7.0974 | $709,740 | 3,330,337 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-02 4:48 pm |
N/A N/A |
OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director |
2,580 | $0 | 2,580 (Direct) |
View |
| 2025-03-31 Option Award |
2025-04-02 4:37 pm |
N/A N/A |
OnKure Therapeutics Inc. | OKUR | Manke Isaac Director |
3,469 | $0 | 3,469 (Direct) |
View |
| 2025-01-27 Option Award |
2025-01-29 8:36 pm |
N/A 2035-01-26 |
OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO |
130,000 | $0 | 130,000 (Direct) |
View |
| 2025-01-27 Option Award |
2025-01-29 8:35 pm |
N/A 2035-01-26 |
OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer |
65,000 | $0 | 65,000 (Direct) |
View |
| 2025-01-27 Option Award |
2025-01-29 8:33 pm |
N/A 2035-01-26 |
OnKure Therapeutics Inc. | OKUR | Hartley Dylan Chief Scientific Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2025-01-27 Option Award |
2025-01-29 8:33 pm |
N/A 2035-01-26 |
OnKure Therapeutics Inc. | OKUR | Agresta Samuel Chief Medical Officer |
45,000 | $0 | 45,000 (Direct) |
View |
Ownership |
2024-10-15 4:08 pm |
N/A N/A |
OnKure Therapeutics Inc. | OKUR | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP Cormorant Private Healthcare Fund V LP Chen Bihua 10% Owner |
0 | $0 | 1,837,739 (Indirect) |
View |
Ownership |
2024-10-09 4:15 pm |
N/A N/A |
OnKure Therapeutics Inc. | OKUR | ACORN BIOVENTURES L.P. ACORN CAPITAL ADVISORS GP LLC Hove Anders D 10% Owner |
0 | $0 | 1,439,674 (Direct) |
View |
| 2024-10-07 Other |
2024-10-09 11:25 am |
N/A N/A |
OnKure Therapeutics Inc. | OKUR | Leonard Braden Michael Former 10% owner of RPHM |
447,815 | $0 | 895,630 (Indirect) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:29 pm |
N/A 2032-01-10 |
OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO |
575,979 | $0 | 575,979 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:28 pm |
N/A 2034-10-03 |
OnKure Therapeutics Inc. | OKUR | Phillips Andrew John Director |
15,300 | $0 | 15,300 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:27 pm |
N/A 2034-10-03 |
OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director |
15,300 | $0 | 15,300 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:27 pm |
N/A 2034-10-03 |
OnKure Therapeutics Inc. | OKUR | Manke Isaac Director |
15,300 | $0 | 15,300 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:26 pm |
N/A 2032-01-10 |
OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer |
158,045 | $0 | 158,045 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:25 pm |
N/A 2034-10-03 |
OnKure Therapeutics Inc. | OKUR | Jansen Valerie Malyvanh Director |
15,300 | $0 | 15,300 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:24 pm |
N/A 2034-10-03 |
OnKure Therapeutics Inc. | OKUR | Hartley Dylan Chief Scientific Officer |
137,603 | $0 | 137,603 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:23 pm |
N/A 2034-10-03 |
OnKure Therapeutics Inc. | OKUR | GREY MICHAEL G Director |
15,300 | $0 | 15,300 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:21 pm |
N/A 2031-07-06 |
OnKure Therapeutics Inc. | OKUR | Carruthers R Michael Director |
23,323 | $0 | 23,323 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:20 pm |
N/A 2034-02-05 |
OnKure Therapeutics Inc. | OKUR | Agresta Samuel Chief Medical Officer |
149,984 | $0 | 149,984 (Direct) |
View |
Ownership |
2024-05-16 08:56 am |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner |
0 | $0 | 3,692,963 (Indirect) |
View |
| 2023-08-28 Exercise |
2023-08-29 5:04 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
15,625 | $1.8 | 148,975 (Direct) |
View |
| 2023-08-28 Exercise |
2023-08-29 5:04 pm |
N/A 2032-12-08 |
Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer |
15,625 | $0 | 148,975 (Direct) |
View |
| 2023-07-26 Gift |
2023-07-27 5:16 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman |
50,000 | $0 | 628,846 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 8:09 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:17 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Blunt Roshawn A. Director |
14,815 | $0 | 14,815 (Direct) |
View |